文献速递瓣膜外科

重度主动脉瓣狭窄患者预期寿命与年龄及手术风险评分的关系

Life Expectancy of Patients With Severe Aortic Stenosis in Relation to Age and Surgical Risk Score.
PubMed 文献 · Ann Thorac Surg · 2023-02-02

基于CURRENT AS注册研究3815例重度主动脉瓣狭窄患者,按STS评分分为低、中、高危三组,比较初始主动脉瓣置换术与保守策略的全因死亡累积发生率,并按年龄分组分析实际生存与日本一般人群预期生存的差异。中位随访3.7年,初始AVR策略的全因死亡累积发生率在三个STS组中均显著低于初始保守策略,年轻患者术后预期寿命缩短更明显。

要点

  • 初始AVR策略的全因死亡累积发生率在低、中、高危三个STS组中均显著低于初始保守策略。
  • 低危患者各年龄组的观察死亡率与预期死亡率相当。
  • 中危且年龄<75岁患者及高危各年龄组患者的死亡率高于预期死亡率。

核心结论

  • 按年龄和STS评分进行风险分层可能有助于评估主动脉瓣置换术后预期寿命缩短,这些发现对选择外科或经导管主动脉瓣置换术的决策有启示。

研究设计与样本

  • CURRENT AS注册研究纳入3815例重度主动脉瓣狭窄患者,低危组1469例(初始AVR 647例、保守策略822例),中危组1642例(初始AVR 433例、保守策略1209例),高危组704例(初始AVR 117例、保守策略587例)。
  • 实际以外科AVR作为初始策略的1163例患者按年龄分为<65岁(185例)、65至74岁(394例)、75至80岁(345例)和>80岁(239例)4组。
  • 日本一般人群预期生存来自日本统计局,手术风险采用胸外科医师学会(STS)评分估计。

主要发现

  • 中位随访3.7年,初始AVR策略的全因死亡累积发生率在低、中、高危三个STS组中均显著低于初始保守策略。
  • 外科AVR后预期寿命缩短尤其在年轻患者中可见。
  • 低危患者各年龄组的观察死亡率与预期死亡率相当。
  • 中危且年龄<75岁患者及高危各年龄组患者的死亡率高于预期死亡率。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is a paucity of data regarding shorter life expectancy after aortic valve replacement (AVR) in patients with severe aortic stenosis (AS). METHODS: Among 3815 patients with severe AS enrolled in the CURRENT AS (Contemporary outcomes after sURgery and medical tREatmeNT in patients with severe Aortic Stenosis) registry, there were 1469 patients (initial AVR: n = 647; conservative strategy: n = 822) with low surgical risk, 1642 patients (initial AVR: n = 433; conservative strategy: n = 1209) with intermediate surgical risk, and 704 patients (initial AVR: n = 117; conservative strategy: n = 587) with high surgical risk. Among 1163 patients who actually underwent surgical AVR as the initial strategy, patients were divided into 4 groups according to age <65 years (n = 185), 65 to 74 (n = 394), 75 to 80 (n = 345), and >80 (n = 239). The expected survival of the general Japanese population was obtained from the Statistics Bureau of Japan. The surgical risk was estimated using The Society of Thoracic Surgery (STS) score. RESULTS: The median follow-up was 3.7 years. The cumulative incidences of all-cause death were significantly lower in the initial AVR strategy than in the initial conservative strategy across the 3 STS groups. Shorter life expectancy after surgical AVR was seen especially in younger patients. The observed mortality in low-risk patients was comparable to the expected mortality across all the age-groups, while intermediate-risk patients aged <75 years, and high-risk patients across all age-groups had higher mortality compared with the expected mortality. CONCLUSIONS: The risk stratification according to age and STS score might be useful to estimate shorter life expectancy after AVR, and these findings have implications for decision making in the choice of surgical or transcatheter AVR.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Taniguchi T, Morimoto T, Yamaji K, et al. Life Expectancy of Patients With Severe Aortic Stenosis in Relation to Age and Surgical Risk Score. Ann Thorac Surg. 2023. PMID: 36739072. doi:10.1016/j.athoracsur.2023.01.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。